Transplantation versus hepatectomy for HCC beyond the Milan criteria: A propensity score analysis

International Journal of Surgery

Volumn 44, Issue , 2017, Pages 33-42

  shen, Jun yi ^a   Li, Chuan ^a   Wen, Tian fu ^a   Yan, Lv nan ^a   Li, Bo ^a   Wang, Wen tao ^a   Yang, Jia yin ^a   Xu, Ming qing ^a   wen, Jun ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Hepatocelluar carcinoma; Liver transplantation; Prognosis; Propensity scoring matching; Surgical resection

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; HEPATITIS B SURFACE ANTIGEN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; COMPARATIVE EFFECTIVENESS; CREATININE BLOOD LEVEL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL ANALYSIS; TUMOR DIFFERENTIATION; COMPARATIVE STUDY; LIVER TUMOR; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

ADULT; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 85021096828     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2017.05.034     Document Type: Article

References (43)

1. Wang, F.S., Fan, J.G., Zhang, Z., Gao, B., Wang, H.Y., The global burden of liver disease: the major impact of China. Hepatology 60 (2014), 2099–2108.
2. Bruix, J., Han, K.H., Gores, G., Llovet, J.M., Mazzaferro, V., Liver cancer: approaching a personalized care. J. hepatology 62 (2015), S144–S156.
3. Zhong, J.H., Ke, Y., Gong, W.F., et al. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma. Ann. Surg. 260 (2014), 329–340.
4. Hsu, C.Y., Hsia, C.Y., Huang, Y.H., et al. Comparison of surgical resection and transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria: a propensity score analysis. Ann. Surg. Oncol. 19 (2012), 842–849.
5. Yin, L., Li, H., Li, A.J., et al. Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT. J. hepatology 61 (2014), 82–88.
6. Qi, X., Wang, D., Su, C., Li, H., Guo, X., Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget 6 (2015), 18715–18733.
7. Mazzaferro, V., Regalia, E., Doci, R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N. Engl. J. Med. 334 (1996), 693–699.
8. Ninomiya, M., Shirabe, K., Facciuto, M.E., et al. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma. J. Am. Coll. Surg. 220 (2015), 297–304 e293.
9. Kim, J.M., Kwon, C.H., Joh, J.W., et al. Patients with unresectable hepatocellular carcinoma beyond Milan criteria: should we perform transarterial chemoembolization or liver transplantation?. Transplant. Proc. 42 (2010), 821–824.
10. Choi, J.Y., Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea. Oncology 81:Suppl 1 (2011), 141–147.
11. Finkenstedt, A., Vikoler, A., Portenkirchner, M., et al. Excellent post-transplant survival in patients with intermediate stage hepatocellular carcinoma responding to neoadjuvant therapy. Liver Int. official J. Int. Assoc. Study Liver, 2015, 10.1111/liv.12966.
12. Xu, X., Lu, D., Ling, Q., et al. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria. Gut, 2015, 10.1136/gutjnl-2014–308513.
13. Lee, K.K., Kim, D.G., Moon, I.S., Lee, M.D., Park, J.H., Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. J. Surg. Oncol. 101 (2010), 47–53.
14. Canter, R.J., Patel, S.A., Kennedy, T., et al. Comparative analysis of outcome in patients with hepatocellular carcinoma exceeding the milan criteria treated with liver transplantation versus partial hepatectomy. Am. J. Clin. Oncol. 34 (2011), 466–471.
15. Fan, H.L., Chen, T.W., Hsieh, C.B., et al. Liver transplantation is an alternative treatment of hepatocellular carcinoma beyond the Milan criteria. Am. J. Surg. 200 (2010), 252–257.
16. D'Agostino, R.B. Jr., Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statistics Med. 17 (1998), 2265–2281.
17. Zheng, S.S., Xu, X., Wu, J., et al. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 85 (2008), 1726–1732.
18. Zhang, J., Zhao, Y., Bai, Y., et al. The significance of serum uric acid level in humans with acute paraquat poisoning. Sci. Rep., 5, 2015, 9168.
19. Xie, Z.R., Luo, Y.L., Xiao, F.M., Liu, Q., Ma, Y., Health-related quality of life of patients with intermediate hepatocellular carcinoma after liver resection or transcatheter arterial chemoembolization. Asian Pac. J. cancer Prev. APJCP 16 (2015), 4451–4456.
20. Heinzow, H.S., Brockmann, J.G., Kohler, M., et al. Liver transplantation versus supraselective transarterial chemoembolization in palliative patients with hepatocellular carcinoma exceeding the Milan Criteria - is it time for a more individual approach?. Ann. Transpl.: Q. Pol. Transplant. Soc. 18 (2013), 515–524.
21. Haberal, M., Emiroglu, R., Karakayali, H., et al. Expanded criteria for hepatocellular carcinoma and liver transplantation. Int. Surg. 92 (2007), 110–115.
22. Bruix, J., Fuster, J., Llovet, J.M., Liver transplantation for hepatocellular carcinoma: foucault pendulum versus evidence-based decision. Liver Transpl. 9 (2003), 700–702.
23. Li, C., Mi, K., Wen, T., et al. A learning curve for living donor liver transplantation. Dig. liver Dis. official J. Italian Soc. Gastroenterology Italian Assoc. Study Liver 44 (2012), 597–602.
24. Jianyong, L., Lunan, Y., Wentao, W., et al. Barcelona clinic liver cancer stage B hepatocellular carcinoma: transarterial chemoembolization or hepatic resection?. Medicine, 93, 2014, e180.
25. Zhu, S.L., Ke, Y., Peng, Y.C., et al. Comparison of long-term survival of patients with solitary large hepatocellular carcinoma of BCLC stage A after liver resection or transarterial chemoembolization: a propensity score analysis. PloS one, 9, 2014, e115834.
26. Li, C., Zhu, W.J., Wen, T.F., et al. Child-Pugh A hepatitis B-related cirrhotic patients with a single hepatocellular carcinoma up to 5 cm: liver transplantation vs. resection. J. Gastrointest. Surg. official J. Soc. Surg. Alimentary Tract 18 (2014), 1469–1476.
27. Llovet, J.M., Updated treatment approach to hepatocellular carcinoma. J. gastroenterology 40 (2005), 225–235.
28. Toso, C., Meeberg, G., Hernandez-Alejandro, R., et al. Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: a prospective validation. Hepatology 62 (2015), 158–165.
29. Yang, S.L., Liu, L.P., Yang, S., et al. Preoperative serum alpha-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma. Br. J. Surg., 10, 2016, 10.02/bjs.10093.
30. Blank, S., Wang, Q., Fiel, M.I., et al. Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal. Ann. Surg. Oncol. 21 (2014), 986–994.
31. Lu, Y., Zhu, M., Li, W., et al. Alpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells. J. Cell. Mol. Med. 20 (2016), 549–558.
32. Li, M.S., Li, P.F., He, S.P., Du, G.G., Li, G., The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma Bel7402 cell line. World J. gastroenterology WJG 8 (2002), 469–475.
33. Huang, J., Li, B.K., Chen, G.H., et al. Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy. J. Gastrointest. Surg. official J. Soc. Surg. Alimentary Tract 13 (2009), 1627–1635.
34. Kluger, M.D., Salceda, J.A., Laurent, A., et al. Liver resection for hepatocellular carcinoma in 313 Western patients: tumor biology and underlying liver rather than tumor size drive prognosis. J. hepatology 62 (2015), 1131–1140.
35. Yip, V.S., Gomez, D., Tan, C.Y., et al. Tumour size and differentiation predict survival after liver resection for hepatocellular carcinoma arising from non-cirrhotic and non-fibrotic liver: a case-controlled study. Int. J. Surg. 11 (2013), 1078–1082.
36. Yaprak, O., Akyildiz, M., Dayangac, M., et al. AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma. Hepatobiliary Pancreat. Dis. Int. HBPD INT 11 (2012), 256–261.
37. DuBay, D., Sandroussi, C., Sandhu, L., et al. Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion. Ann. Surg. 253 (2011), 166–172.
38. Shah, S.A., Tan, J.C., McGilvray, I.D., et al. Does microvascular invasion affect outcomes after liver transplantation for HCC? A histopathological analysis of 155 consecutive explants. J. Gastrointest. Surg. official J. Soc. Surg. Alimentary Tract 11 (2007), 464–471.
39. Shetty, K., Timmins, K., Brensinger, C., et al. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl. 10 (2004), 911–918.
40. Cillo, U., Vitale, A., Bassanello, M., et al. Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann. Surg. 239 (2004), 150–159.
41. Liu, X., Meng, Q.H., Ye, Y., et al. Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer. Carcinogenesis 36 (2015), 243–248.
42. Chan, S.C., Fan, S.T., Selection of patients of hepatocellular carcinoma beyond the Milan criteria for liver transplantation. Hepatobiliary Surg. Nutr. 2 (2013), 84–88.
43. Lei, J., Yan, L., Outcome comparisons among the Hangzhou, Chengdu, and UCSF criteria for hepatocellular carcinoma liver transplantation after successful downstaging therapies. J. Gastrointest. Surg. official J. Soc. Surg. Alimentary Tract 17 (2013), 1116–1122.